ICD9
- 530.11 Reflux esophagitis
- 530.81 Esophageal reflux
ICD10
- K21 Gastro-esophageal reflux disease
- K21.0 Gastro-esophageal reflux disease with esophagitis
- K21.9 Gastro-esophageal reflux disease without esophagitis
GASTROINTESTINAL BLEEDING
Czarina E. Sánchez
•
Leon D. Sánchez
BASICS
DESCRIPTION
- Bleeding from GI tract:
- Upper GI tract: Proximal to ligament of Treitz
- Lower GI tract: Distal to ligament of Treitz to anus
- Mortality rate:
- 10% overall; from <5% in children up to 25% for adults of age >70
- Upper GI bleed (UGIB) 6–8%; variceal 30–50%
- Lower GI bleed (LGIB) 2–4%
ETIOLOGY
Upper Gi Bleed (UGIB):
- Ulcerative disease of upper GI tract:
- Peptic ulcer disease (40%):
- Helicobacter pylori
infection
- Drug-induced (NSAIDs, aspirin, glucocorticoids, K
+
supplements, Fe supplements)
- Gastric or esophageal erosions (25%):
- Reflux esophagitis
- Infectious esophagitis (
Candida
, HSV, CMV)
- Pill-induced esophagitis
- Esophageal foreign body
- Gastritis and stress ulcerations:
- Toxic agents (NSAIDs, alcohol, bile)
- Mucosal hypoxia (trauma, burns, sepsis)
- Cushing ulcers from severe CNS damage
- Chemotherapy
- Portal HTN:
- Esophageal or gastric varices (10%)
- Portal hypertensive gastropathy
- Arteriovenous malformations:
- Aortoenteric fistula (s/p aortoiliac surgery)
- Hereditary hemorrhagic telangiectasia (Osler—Weber–Rendu syndrome)
- Dieulafoy vascular malformations
- Gastric antral vascular ectasia (GAVE or watermelon stomach)
- Idiopathic angiomas
- Mallory–Weiss tear (5%)
- Gastric and esophageal tumors
- Pancreatic hemorrhage
- Hemobilia
- Strongyloides stercoralis
infection
Lower Gi Bleed (LGIB):
- Diverticulosis (33%)
- Cancer or polyps (19%)
- Colitis (18%):
- Ischemic, inflammatory, infectious, or radiation
- Vascular:
- Angiodysplasia (8%)
- Radiation telangiectasia
- Aortocolonic fistula
- Inflammatory bowel disease:
- Crohn's disease and ulcerative colitis
- Postpolypectomy
- Anorectal (4%):
- Hemorrhoids (internal and external)
- Anal fissures
- Anorectal varices
- Rectal ulcer
- Foreign body
Pediatric Considerations
Meckel diverticulum and intussusception are the most common causes of LGIB in children.
DIAGNOSIS
SIGNS AND SYMPTOMS
- Both UGIB and LGIB may present with signs/symptoms of hypovolemia
- UGIB classic presentation:
- Hematemesis or coffee ground emesis
- Melena: Black tarry stool
- LGIB classic presentation:
- Hematochezia: Bright red or maroon stool
ALERT
Hematochezia classically signals an LGIB, but can also be seen with brisk UGIB.
History
- Hematemesis and melena most common
- Coffee ground emesis
- Black stools
- Bright red blood per rectum
- Abdominal pain
- Weakness or lightheadedness
- Dyspnea
- Confusion or agitation
Physical-Exam
- Tachycardia
- Hypotension
- Pale conjunctiva
- Dry mucous membranes
- Bloody, melanotic, or heme-positive stools
- Shock
ESSENTIAL WORKUP
- CBC, coagulation studies, electrolytes
- Perform ENT exam. Distinguish between hemoptysis and hematemesis:
- Pulmonary source:
- Bright red and frothy in appearance
- Sputum mixed with blood is likely pulmonary
- pH >7
- GI source:
- Dark red/brown blood, ± gastric contents
- Associated with nausea/vomiting
- pH <7
- Consider nasogastric lavage:
- Might help determine if bleeding is ongoing and facilitate endoscopy
- Controversialstudies have failed to demonstrate outcome benefit. False-negatives, if bleeding beyond pylorus.
- Rectal exam:
- Inspect for hemorrhoids and anal fissures
- Examine stool color
- False-positive Hemoccult result:
- Raw red meat
- Iron supplements
- Fruits: Cantaloupe, grapefruit, figs
- Vegetables: Raw broccoli, cauliflower, radish
- Methylene blue, chlorophyll
- Iodide, bromide
- False-negative Hemoccult result:
- Bile
- Mg-containing antacids
- Ascorbic acid
- Agents causing black stools, but negative Hemoccult:
- Iron
- Charcoal
- Bismuth (i.e., Pepto-Bismol)
- Food dyes
- Beets
Pediatric Considerations
Bloody stool in newborns may be caused by the infant swallowing maternal blood.
DIAGNOSIS TESTS & NTERPRETATION
Lab
- CBC:
- Anemia (low mean corpuscular volume seen with chronic blood loss)
- Thrombocytopenia
- Electrolytes, BUN, creatinine, glucose
- Coagulation profile
- Lactate
- LFTs, if upper GI bleeding suspected
- Type and screen/cross for active bleeding or unstable vital signs
- BUN/Cr ratio >36 has a high sensitivity but low specificity for UGIB
ALERT
Hematocrit can remain normal for a period after acute blood loss; a drop may not be immediately seen.
Imaging
- Upright CXR if concern for aspiration or perforation
- Angiography/arterial embolization:
- Effective for identifying large, active bleeding
- Radionucleotide (tagged red blood cell) scan:
- Effective for identifying slow, active bleeding
Diagnostic Procedures/Surgery
- Anoscopy:
- For suspected internal hemorrhoids or fissures
- Esophagogastroduodenoscopy (EGD):
- Diagnostic and possibly therapeutic
- Colonoscopy:
- Diagnostic only
- Best after adequate bowel prep
- Bowel resection:
- Reserved for refractory bleeding
DIFFERENTIAL DIAGNOSIS
- Epistaxis
- Oropharyngeal bleeding
- Hemoptysis
- Hematuria
- Vaginal bleeding
- Visceral trauma
TREATMENT
PRE HOSPITAL
- Stabilize airway
- Intubate for massive UGIB, if patient unable to protect airway
- Establish access
- Insert large-bore IV (16–18g) and administer crystalloid to keep SBP >90 mm Hg
- Attempt 2nd IV line en route to hospital
INITIAL STABILIZATION/THERAPY
- Assess airway, breathing, and circulation
- Control airway in unstable patients, with massive bleeding, or unable to protect airway
- Initiate 2 large-bore (16 g) IVs and place on cardiac monitor
- Provide volume:
- Administer 1 L NS bolus (peds: 20 mL/kg) and repeat once, if necessary
- Transfuse RBCs if significant anemia or unstable after crystalloid boluses
- Cross-matched or type-specific blood, if available
- Otherwise, O negative for premenopausal women, O positive for others
- Provide fresh frozen plasma (FFP) along with RBC transfusion in ratio of 1:2–4. For patients requiring massive transfusion, consider adding FFP and platelets in 1:1:1 ratio with RBCs
- For coagulopathy, administer FFP and vitamin K (if INR >1.5) and platelets (if platelets <50,000/uL)
ED TREATMENT/PROCEDURES
- Consult gastroenterology for any significant GI bleeding
- Consider surgical consult and/or interventional radiology for massive active bleeding, unstable patient, or evidence of perforation
- Place Foley catheter to monitor urine output
- Consider nasogastric tube (NGT), as above
- Blood transfusion indications:
- Significant anemia:
- Hemoglobin <7 g/dL
- Hemoglobin <10 g/dL when at increased risk of ischemia (e.g., CAD and CVA)
- Evidence of end-organ ischemia
- Ongoing chest pain/ischemic EKG changes
- Unstable vital signs despite crystalloid bolus
ALERT
Avoid overtransfusion in variceal bleeding; it can precipitate further bleeding
- UGIB treatment
- IV proton pump inhibitor (PPI) (e.g., pantoprazole)
- Octreotide for suspected variceal bleeding
- Consider vasopressin for active variceal bleeding:
- Bleeding cessation benefits may be counterbalanced by increased mortality due to ischemia
- Administer with IV nitroglycerin to reduce tissue ischemia
- High risk for active bleeding with 2 out of 3 risk factors:
- Bright blood from NGT
- Hemoglobin <8 g/dL
- WBC >12,000/uL
- Emergent endoscopy
- Therapeutic options:
- Cauterization of bleeding ulcers/vessels
- Endoscopic sclerotherapy
- Balloon tamponade with Blakemore tube is a last resort for varices
- In cirrhotics with UGIB prophylactic antibiotic use reduce bacterial infections and all cause mortality
- LGIB treatment
- Consider angiography for massive, active bleeding with directed vasopressin infusion
- Consider bowel resection for massive bleeding refractory to medical management